CEEOG publications Eckhardt S, Juhos E, Hindy I, Jelic S, Koza I, László G, Mechl Z, Nagykálnay T, Pawlicki M, Schoket Z, et al. Activity of epirubicin and dibromodulcitol in advanced breast cancer. Results of the South-East European Oncology Group Study. Oncology. 1988;45(6):409-12. Eckhardt S, Hernádi Z, Thurzó L, Telekes A, Sopkova B, Mechl Z, Pawlicki M, Kerpel-Fronius S. Phase II clinical evaluation of etoposide (VP-16-213, Vepesid) as a second-line treatment in ovarian cancer. Results of the South-East European Oncology Group (SEEOG) Study. Oncology. 1990;47(4):289-95. Eckhardt...

CEEOG conference communication Wu NC, Wong W, Ho KE, Chu VC, Rizo A, Davonport S, Kelly D, Makar R, Jassem J, Duchnowska R, Biernat W, Radecka B, Fujita T, Klein JL, Stonecypher M, Otha S, Juhl H, Weidler JM, Bates M, Press MF. High concordance of ER, PR, HER2 and Ki67 by central IHC and FISH with MRNA measurements by GeneXpert breast cancer stratifier assay [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P1-03-03.

 Conference abstracts S. Kerpel-Fronius, Z. Mechl, J. Csetenyi, T. Nagykalnai, F. Gyergyay, J. Jassem et al.: Pharmacocinetic and response rate of 5-Fluorouracil given in daily 4h infusion combined with cisplatin in head and neck cancer. Phase I-II study. Proc. Annual ASCO meeting, 1988, 150. K. Kolaric, S. Eckhardt, J. Jassem, E. Kanitz, A. Tamas, C. Intini, Z. Schoket, M. Pawlicki. Phase II randomized study of high-dose epirubicin combined with either cyclophosphamide or cisplatin in small cell lung cancer. Proc 16 Int Congress of Chemother,...